Emmessar Biotech & Nutrition Limited (EMMESSA) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE634B01016
Key metrics
- Market Cap
- ₹12 Cr
- P/E Ratio
- 30.28
- EPS
- 0.79
- Book Value
- 16.24
- P/B Ratio
- 1.47
- ROE
- 5.37%
- ROCE
- -17.91%
- Debt / Equity
- —
- Net Margin
- 117.56%
- Revenue Growth
- -39.3%
- Profit Growth
- 37.86%
- Dividend Yield
- —
- 52W High
- ₹42.75
- 52W Low
- ₹18.42
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Emmessar Biotech & Nutrition Limited
Emmessar Biotech & Nutrition Limited, a healthcare company, provides healthcare and nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles. In addition, the company offers vedaceuticals, an ayurveda disease curing medicine. Further, it provides healthcare products for dermatology, osteoporosis, anti-ageing, physical ailments, and burns, including radiation. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 61.57%
The full Emmessar Biotech & Nutrition Limited analysis
Create a free account to open the complete EMMESSA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.